---
figid: PMC10179295__ijms-24-08245-g002
figtitle: Paxillin participates in Wnt, integrin-FAK, and TGFB signaling pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10179295
filename: PMC10179295__ijms-24-08245-g002.jpg
figlink: /pmc/articles/PMC10179295/figure/F2
number: F2
caption: Paxillin participates in Wnt, integrin-FAK, and TGF-β signaling pathways.
  Paxillin induces FA recombination through the Wnt5a/JNK signaling pathway. HIMOXOL,
  Br-HIMOLID, ST inhibitor, and HPW-RX40 inhibit tumor progression by inhibiting the
  integrin-FAK signaling pathway to inhibit paxillin expression or phosphorylation
  level, while HAb18G/CD147 does the opposite. GDP-9 promotes paxillin expression
  and paxillin phosphorylation through Smad-dependent pathways. CX-4945 can reduce
  paxillin expression and paxillin phosphorylation by inhibiting the TGF-β signaling
  pathway. Hesperetin can inhibit TGF-β-mediated Fyn activation by reducing paxillin
  phosphorylation to inhibit RhoA expression and rock activation, which affects tumor
  migration and invasion
papertitle: The Role of Paxillin Aberrant Expression in Cancer and Its Potential as
  a Target for Cancer Therapy
reftext: Weixian Liu, et al. Int J Mol Sci. 2023 May;24(9).
year: '2023'
doi: 10.3390/ijms24098245
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: paxillin | aberrant expression | metastasis | mechanism | treatment target
automl_pathway: 0.9730343
figid_alias: PMC10179295__F2
figtype: Figure
redirect_from: /figures/PMC10179295__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10179295__ijms-24-08245-g002.html
  '@type': Dataset
  description: Paxillin participates in Wnt, integrin-FAK, and TGF-β signaling pathways.
    Paxillin induces FA recombination through the Wnt5a/JNK signaling pathway. HIMOXOL,
    Br-HIMOLID, ST inhibitor, and HPW-RX40 inhibit tumor progression by inhibiting
    the integrin-FAK signaling pathway to inhibit paxillin expression or phosphorylation
    level, while HAb18G/CD147 does the opposite. GDP-9 promotes paxillin expression
    and paxillin phosphorylation through Smad-dependent pathways. CX-4945 can reduce
    paxillin expression and paxillin phosphorylation by inhibiting the TGF-β signaling
    pathway. Hesperetin can inhibit TGF-β-mediated Fyn activation by reducing paxillin
    phosphorylation to inhibit RhoA expression and rock activation, which affects
    tumor migration and invasion
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BSG
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - RHOA
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - TGFB1
  - TGFB2
  - TGFB3
  - TGFBR1
  - TGFBR2
  - SMAD2
  - SMAD3
  - PTK2
  - FYN
  - SMAD4
  - MAPK8
  - ROCK1
  - ROCK2
  - Hesperetin
---
